You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
IFR:淡馬錫投資的陸道培醫療計劃香港IPO籌資5億美元

據IFR報道,陸道培醫療計劃最早於今年提交香港上市申請,籌資5億美元。

陸道培醫療集團由血液病專家陸道培院士於2001年創建,經過近20年的發展,目前已經擁有河北陸道培血液病醫院、北京陸道培醫院、北京陸道培血液病醫院和上海道培醫院四家營利性三級血液病專科醫院,成爲中國血液病領域首屈一指的民營專科醫療集團。

國內“院士辦醫”尚處探索階段,業內僅有樹蘭醫療和陸道培醫療集團,資本對“院士辦醫”熱情高漲。

2020年7月,陸道培醫療集團宣佈完成超過5億元人民幣B輪融資,本輪融資由新加坡主權基金淡馬錫領投,Investcorp跟投。浩悅資本在本次交易中擔任獨家財務顧問。

2020年9月,陸道培醫療集團又完成超過1億元人民幣B+輪股權融資,本輪融資由約印醫療基金領投,招商證券資本、軟銀中國資本、衆合資本及老股東樸道醫療等跟投。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account